Total Payments
$1,102
2023 Payments
$128.48
Companies
18
Transactions
28
Medicare Patients
2,289
Medicare Billing
$339,795
Payment Breakdown by Category
Food & Beverage$1,090 (98.9%)
Education$11.97 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,090 | 27 | 98.9% |
| Education | $11.97 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $168.55 | 3 | $0 (2021) |
| Abbott Laboratories | $161.30 | 2 | $0 (2022) |
| Daiichi Sankyo Inc. | $147.49 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $118.82 | 1 | $0 (2018) |
| Progenics Pharmaceuticals, Inc. | $107.63 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $91.33 | 2 | $0 (2018) |
| Janssen Biotech, Inc. | $59.20 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $44.30 | 3 | $0 (2022) |
| Mallinckrodt LLC | $29.44 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.61 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $128.48 | 2 | Progenics Pharmaceuticals, Inc. ($107.63) |
| 2022 | $221.81 | 6 | Abbott Laboratories ($161.30) |
| 2021 | $122.14 | 6 | Amgen Inc. ($44.80) |
| 2020 | $145.69 | 2 | Amgen Inc. ($123.75) |
| 2019 | $40.66 | 2 | Daiichi Sankyo Inc. ($22.50) |
| 2018 | $298.92 | 5 | Daiichi Sankyo Inc. ($124.99) |
| 2017 | $144.12 | 5 | AstraZeneca Pharmaceuticals LP ($73.77) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/07/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $107.63 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/31/2023 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $20.85 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 10/13/2022 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug), TASIGNA | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: ONCOLOGY | ||||||
| 07/20/2022 | Abbott Laboratories | ABSORB GT1 (Device) | Food and Beverage | In-kind items and services | $88.05 | General |
| Category: Vascular | ||||||
| 07/20/2022 | Abbott Laboratories | ABSORB GT1 (Device) | Food and Beverage | In-kind items and services | $73.25 | General |
| Category: Vascular | ||||||
| 07/06/2022 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug), TASIGNA | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: ONCOLOGY | ||||||
| 04/20/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2021 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Oncology | ||||||
| 10/19/2021 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: ONCOLOGY | ||||||
| 05/06/2021 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Oncology | ||||||
| 04/27/2021 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Hematology | ||||||
| 03/31/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $11.97 | General |
| Category: ONCOLOGY | ||||||
| 03/29/2021 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2020 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Oncology | ||||||
| 02/27/2020 | Amgen Inc. | Kyprolis (Drug), XGEVA | Food and Beverage | In-kind items and services | $123.75 | General |
| Category: Oncology | ||||||
| 09/24/2019 | Daiichi Sankyo Inc. | Turalio (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Oncology | ||||||
| 03/06/2019 | Novartis Pharmaceuticals Corporation | SANDOSTATIN (Drug), VOTRIENT | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Anemia | ||||||
| 05/23/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $118.82 | General |
| 04/03/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Oncology | ||||||
| 02/23/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Oncology | ||||||
| 12/20/2017 | Janssen Scientific Affairs, LLC | YONDELIS (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Oncology | ||||||
| 10/25/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: ACUTE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 784 | 1,374 | $356,491 | $115,355 |
| 2022 | 13 | 657 | 960 | $245,850 | $70,038 |
| 2021 | 11 | 470 | 976 | $410,582 | $95,773 |
| 2020 | 10 | 378 | 764 | $269,424 | $58,628 |
Total Patients
2,289
Total Services
4,074
Medicare Billing
$339,795
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 303 | $119,382 | $45,645 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 222 | $61,938 | $24,329 | 39.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $45,144 | $10,095 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 106 | $19,186 | $8,104 | 42.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 80 | $20,560 | $5,344 | 26.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $21,605 | $5,016 | 23.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 44 | $21,340 | $4,782 | 22.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $16,548 | $3,809 | 23.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 217 | 438 | $6,570 | $3,634 | 55.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $7,887 | $1,573 | 19.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $8,195 | $1,549 | 18.9% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 12 | 12 | $8,136 | $1,474 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 109 | 109 | $64,746 | $16,141 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 134 | $38,783 | $14,686 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 87 | $34,278 | $13,717 | 40.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 52 | 52 | $20,488 | $5,184 | 25.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 32 | $15,520 | $3,575 | 23.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 58 | $15,023 | $3,401 | 22.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 35 | $12,880 | $3,009 | 23.4% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2022 | 18 | 18 | $12,204 | $2,957 | 24.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $11,175 | $2,735 | 24.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 20 | 21 | $4,664 | $1,531 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 24 | $6,703 | $1,147 | 17.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 190 | 364 | $5,448 | $1,062 | 19.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $3,938 | $893.90 | 22.7% |
About Dr. Jae Cho, MD
Dr. Jae Cho, MD is a Hematology & Oncology healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2011. The National Provider Identifier (NPI) number assigned to this provider is 1790084663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jae Cho, MD has received a total of $1,102 in payments from pharmaceutical and medical device companies, with $128.48 received in 2023. These payments were reported across 28 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,090).
As a Medicare-enrolled provider, Cho has provided services to 2,289 Medicare beneficiaries, totaling 4,074 services with total Medicare billing of $339,795. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location White Plains, NY
- Active Since 03/17/2011
- Last Updated 11/14/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1790084663
Products in Payments
- ABSORB GT1 (Device) $161.30
- INJECTAFER (Drug) $124.99
- Kyprolis (Drug) $123.75
- PYLARIFY (Drug) $107.63
- LYNPARZA (Drug) $73.77
- IMBRUVICA (Drug) $53.57
- OFIRMEV (Drug) $29.44
- LUMAKRAS (Drug) $29.07
- NINLARO (Drug) $27.61
- SCEMBLIX (Drug) $26.14
- YONDELIS (Drug) $24.38
- Turalio (Drug) $22.50
- Nerlynx (Drug) $21.88
- clonoSEQ (Device) $20.85
- LIBTAYO (Biological) $20.50
- DARZALEX (Biological) $20.00
- SANDOSTATIN (Drug) $18.16
- IMFINZI (Drug) $17.56
- Abraxane (Drug) $16.53
- Nplate (Biological) $15.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in White Plains
Dr. Stuart Feldman, Md, MD
Hematology & Oncology — Payments: $3,615
Hematology & Oncology $3,615
Dr. Dan Costin, Md, MD
Hematology & Oncology — Payments: $1,968
Hematology & Oncology $1,968
Dr. Matthew Weissler, M.d, M.D
Hematology & Oncology — Payments: $1,496
Hematology & Oncology $1,496
Yael Zack, M.d, M.D
Hematology & Oncology — Payments: $1,080
Hematology & Oncology $1,080
Dr. Karen Green, Md, MD
Hematology & Oncology — Payments: $887.16
Hematology & Oncology $887.16
Dr. Della Makower, Md, MD
Hematology & Oncology — Payments: $785.69
Hematology & Oncology $785.69